MJ Lab, based at Harvard Medical School and MGH Institute for Technology Assessment, seeks two postdoctoral fellows to join a new project funded by the U.S. FDA. Working in an interdisciplinary research group, the postdoctoral fellows will directly report to the Principal Investigator (Dr. Jalali) and have the opportunity to work with the team of investigators at Harvard, Stanford, Cornell, Boston University, University of Southern California, and Oregon State University. The candidates will also supervise research associates and interns and will be involved in the preparation of grant applications. These positions are best for individuals interested in faculty positions.
Following our current development of a system dynamics simulation model (2018-present), the goal of this new project is to work collaboratively with FDA to expand the model to include a cost-effectiveness analysis of interventions and policies to reduce opioid-related illnesses, including opioid misuse, use disorder, and overdose.
We will broaden the scope of the model to account for impacts resulting from opioid-related illnesses—such as reduced quality of life, lost productivity, costs to society, and the intended and unintended outcomes resulting from opioid-related policies and interventions (e.g., increased untreated pain)—on individuals and society that go beyond the outcomes currently included in the model.
Selected candidates can join the lab immediately. Recent graduates and PhD candidates graduating in December 2020 are encouraged to apply. PhD candidates graduating in May 2021 will be considered upon the availability of the positions.
Candidates will work closely with Dr. Jalali and the team of postdocs, RAs, and interns in a collaborative, productive, and friendly research environment. The lab is located at the Institute for Technology Assessment: 101 Merrimac St, Boston, MA 02114; however, due to the COVID-19 pandemic, remote collaborations are available.